logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 1
  • 1
    Shah, Nikunj Gunvantrai, Mr.
    Born in November 1981
    Individual (6 offsprings)
    Officer
    2011-12-05 ~ now
    OF - Director → CIF 0
    Mr Nikunj Gunvantrai Shah
    Born in November 1981
    Individual (6 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

NGS PHARMA LTD

Period: 2011-12-05 ~ now
Company number: 07871679
Registered name
NGS PHARMA LTD - now
Recent Standard Industrial Classification
47730 - Dispensing Chemist In Specialised Stores
Brief company account
Property, Plant & Equipment
125,581 GBP2025-03-31
120,401 GBP2024-03-31
Fixed Assets
125,581 GBP2025-03-31
120,401 GBP2024-03-31
Total Inventories
93,440 GBP2025-03-31
93,967 GBP2024-03-31
Debtors
316,646 GBP2025-03-31
332,074 GBP2024-03-31
Cash at bank and in hand
798,910 GBP2025-03-31
820,786 GBP2024-03-31
Current Assets
1,208,996 GBP2025-03-31
1,246,827 GBP2024-03-31
Creditors
-260,298 GBP2025-03-31
-314,988 GBP2024-03-31
Net Current Assets/Liabilities
948,698 GBP2025-03-31
931,839 GBP2024-03-31
Total Assets Less Current Liabilities
1,074,279 GBP2025-03-31
1,052,240 GBP2024-03-31
Creditors
Non-current
-10,633 GBP2025-03-31
-19,433 GBP2024-03-31
Net Assets/Liabilities
1,063,646 GBP2025-03-31
1,032,807 GBP2024-03-31
Equity
Called up share capital
100 GBP2025-03-31
100 GBP2024-03-31
Retained earnings (accumulated losses)
1,063,546 GBP2025-03-31
1,032,707 GBP2024-03-31
Average Number of Employees
72024-04-01 ~ 2025-03-31
72023-04-01 ~ 2024-03-31
Intangible Assets - Gross Cost
Net goodwill
670,000 GBP2025-03-31
670,000 GBP2024-03-31
Intangible Assets - Accumulated Amortisation & Impairment
Net goodwill
670,000 GBP2025-03-31
670,000 GBP2024-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
28,837 GBP2025-03-31
28,837 GBP2024-03-31
Furniture and fittings
114,568 GBP2025-03-31
110,872 GBP2024-03-31
Property, Plant & Equipment - Gross Cost
190,853 GBP2025-03-31
170,583 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
24,443 GBP2025-03-31
22,323 GBP2024-03-31
Furniture and fittings
40,187 GBP2025-03-31
27,550 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
65,272 GBP2025-03-31
50,182 GBP2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Land and buildings, Under hire purchased contracts or finance leases
333 GBP2024-04-01 ~ 2025-03-31
Plant and equipment
2,120 GBP2024-04-01 ~ 2025-03-31
Furniture and fittings
12,637 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
15,090 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment
Plant and equipment
4,394 GBP2025-03-31
6,514 GBP2024-03-31
Furniture and fittings
74,381 GBP2025-03-31
83,322 GBP2024-03-31
Finished Goods
93,440 GBP2025-03-31
93,967 GBP2024-03-31
Trade Debtors/Trade Receivables
Current
95,927 GBP2025-03-31
123,211 GBP2024-03-31
Prepayments/Accrued Income
Current
1,615 GBP2025-03-31
1,649 GBP2024-03-31
Other Debtors
Current
179,473 GBP2025-03-31
175,763 GBP2024-03-31
Amount of value-added tax that is recoverable
Current
30,079 GBP2025-03-31
31,451 GBP2024-03-31
Amounts owed by directors
Current
9,552 GBP2025-03-31
Trade Creditors/Trade Payables
Current
204,600 GBP2025-03-31
259,310 GBP2024-03-31
Bank Borrowings/Overdrafts
Current
10,200 GBP2025-03-31
11,400 GBP2024-03-31
Corporation Tax Payable
Current
35,911 GBP2025-03-31
25,376 GBP2024-03-31
Other Taxation & Social Security Payable
Current
332 GBP2025-03-31
346 GBP2024-03-31
Other Creditors
Current
6,755 GBP2025-03-31
8,680 GBP2024-03-31
Accrued Liabilities/Deferred Income
Current
2,500 GBP2025-03-31
2,500 GBP2024-03-31
Amounts owed to directors
Current
7,376 GBP2024-03-31
Creditors
Current
260,298 GBP2025-03-31
314,988 GBP2024-03-31
Bank Borrowings/Overdrafts
Non-current
10,633 GBP2025-03-31
19,433 GBP2024-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2025-03-31
Nominal value of allotted share capital
Class 1 ordinary share
1 GBP2024-04-01 ~ 2025-03-31

  • NGS PHARMA LTD
    Info
    Registered number 07871679
    39 Chapel Road, West Bergholt, Colchester, Essex CO6 3JB
    PRIVATE LIMITED COMPANY incorporated on 2011-12-05 (14 years 9 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-12-05
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 14 July 2026 and licensed under the Open Government Licence v3.0.